Targeting Pleckstrin-2/Akt Signaling Reduces Proliferation in Myeloproliferative Neoplasm Models

Researchers revealed a Plek2/Akt complex that drove cell proliferation and could be targeted by a class of antiproliferative compounds for myeloproliferative neoplasm therapy.